Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06480695 · ClinicalTrials.gov registry record · NA

Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females

A NA study of Menopause, sponsored by University of Virginia.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06480695: Recruiting NA study of Menopause, sponsored by University of Virginia.

NCT06480695 is a NA study of Menopause that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 40 participants, below the 9,393-participant average among 54 other Menopause trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06480695, a NA study of Menopause, is actively recruiting participants, sponsored by University of Virginia.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Menopause greatly increases cardiovascular disease risk (CVD). Current exercise guidelines are inadequate to ameliorate this risk and higher intensity exercise may be necessary for cardiovascular benefits in postmenopausal females. Oral nitrate supplementation enhances exercise performance and CVD risk profile in several clinical conditions. The investigators recently reported that 3-days of nitrate supplementation in postmenopausal females enhances acute post-exercise vascular function, in an intensity dependent manner. The effects of nitrate supplementation and exercise training over a longer training program remains unexplored. This investigation will examine the impact of exercise training intensity with and without inorganic nitrate supplementation, on CVD and fitness outcomes. Postmenopausal females will be tested for maximal oxygen uptake and lactate threshold before randomization to one of four groups: that inorganic nitrate-rich beetroot juice, or beetroot juice with nitrate extracted; and assigned to one-month of calorie matched high-intensity or moderate-intensity exercise training. Vascular function and fitness will be evaluated before and after training.

Primary Outcome

Participants will be placed in a supine position with their left forearm slightly extended and supinated with legs straight. The arteries will be imaged using a high-resolution 7.5MHz linear array transducer at rest, during 5 minutes of forearm occlusion via cuff inflation, and continuously for 3 minutes post-occlusion; an EKG trigger will be used to capture images during end-diastole of the cardiac cycle.

Conditions Studied

Interventions

  • BEHAVIORAL Moderate Intensity Exercise
  • DIETARY_SUPPLEMENT Nitrate-Rich Beetroot Juice
  • BEHAVIORAL High Intensity Exercise
  • DIETARY_SUPPLEMENT Nitrate-Depleted Placebo Beetroot Juice

Study Locations (1)

Virginia

  • Student Health and Wellness Building - Department of Kinesiology - Charlottesville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-07-01
Est. Completion 2026-12-31
Phase NA
University of Virginia

449 total trials

What NCT06480695 shows while recruiting

NCT06480695 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 9,393-participant average among 54 other Menopause trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Menopause appearing as the primary indexed condition, and to 4 interventions - of which Moderate Intensity Exercise is the first listed.

NCT06480695 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT06480695 about?

NCT06480695 is a clinical study titled "Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females". Menopause greatly increases cardiovascular disease risk (CVD). Current exercise guidelines are inadequate to ameliorate this risk and higher intensity exercise may be necessary for cardiovascular benefits in postmenopausal females. Oral nitrate supplementation enhances exercise performance and CVD r...

What is the current status of trial NCT06480695?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06480695 study?

This clinical trial studies the following conditions: Menopause.

What interventions are being tested in trial NCT06480695?

The interventions under investigation include: Moderate Intensity Exercise (BEHAVIORAL), Nitrate-Rich Beetroot Juice (DIETARY_SUPPLEMENT), High Intensity Exercise (BEHAVIORAL), Nitrate-Depleted Placebo Beetroot Juice (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06480695?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06480695 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Menopause

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06480695's enrollment target sits among peer trials

40 37th of 54 higher than 16 of 54 other Menopause trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Menopause trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06480695, the US trial registry maintained by the National Library of Medicine. NCT06480695 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.